J&J’s Rybrevant and cancer vaccines are showing benefit, with detailed data presented at ASCO. Credit: Hindi Studio / Shutterstock.com
During the American Society of Clinical Oncology (ASCO) meeting 2026, data were presented for a number of cancer vaccines, including in melanoma, glioblastoma and head and neck squamous cell carcinoma.
Cancer vaccines are working their way through clinical trials; however, there may be some difficulties due to growing scepticism around their safety among high-ranking US health agency employees – including the US Health Secretary, Robert F Kennedy Jr (RFK Jr). Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Find out more
